The Philippine Food and Drug Administration (FDA) has issued FDA Circular No. 2025-006, announcing the implementation of an Online User Account Registration and Renewal System within the FDA eServices Platform. This circular establishes a centralized and automated system for the creation, activation, renewal, and management of user accounts across all FDA online portals.
The circular applies to all users accessing FDA electronic systems, including ePortal, ePortal2, and the RRD Portal, and replaces previous manual and semi-manual account management processes.
Read the full circular here: FDA Circular No. 2025-006 (available in English). [PDF]
Purpose of the Circular
- To automate and centralize user account registration, activation, and renewal across all FDA online portals.
- To eliminate manual confirmation and intervention by FDA Centers and Offices in user account management.
- To standardize the validity period and renewal process for FDA user accounts.
- To improve system efficiency, security, and accessibility within the FDA eServices Platform.
Scope of Application
This circular applies to all users accessing FDA electronic systems, including but not limited to:
- FDA ePortal
- FDA ePortal2
- RRD Portal
Key Highlights
Online User Account Registration System
User account creation and activation shall be conducted exclusively through the Online User Account Registration module within the FDA eServices Platform (https://eservices.fda.gov.ph/account_registration).
Additional procedural details are provided in Annex A – Procedures in Acquiring a User Account in FDA Portals, which outlines the step-by-step process for account registration and activation: FDA Circular No. 2025-006 Annex A [PDF]
All account creation and activation processes are fully automated, eliminating the need for manual validation or approval by any FDA Center or Office.
User Account Validity and Expiration
- User accounts shall be valid for two (2) years from the date of issuance.
- Accounts will automatically expire if no FDA application is filed within one (1) year from the date of issuance.
User Account Renewal
- User account renewal may be initiated and processed automatically through the system.
- Upon successful verification of valid login credentials, account validity will be extended for another two (2) years from the date of renewal.
Repeal of Previous Issuances
This circular repeals the following FDA issuances:
- FDA Circular No. 2023-006
- FDA Circular No. 2020-033
- FDA Circular No. 2016-004
- FDA Advisory No. 2020-1929
User accounts previously issued by the FDA Central Office (FDAC) and FDA Centers prior to the effectivity of this Circular shall remain valid and unaffected.
User Account Retrieval
Requests for retrieval of user accounts shall be submitted via email to FDAC (fdac@fda.gov.ph) and will be subject to validation.
Implications to Clients
Clients and stakeholders must ensure that their FDA user accounts are properly registered and renewed within the FDA eServices Platform to maintain uninterrupted access to FDA online systems.
Failure to maintain an active and compliant user account may result in delays or inability to file and process:
- License to Operate (LTO) applications
- Certificate of Product Registration (CPR) applications
- Other FDA regulatory submissions
This update is provided for regulatory awareness and operational planning purposes.
Contact Information
For inquiries or support regarding FDA user account registration, renewal, or access to the FDA eServices Platform in the Philippines, please contact sales@andamanmed.com.
Effective Date
This Circular takes effect immediately upon posting on the FDA website and upon publication in a newspaper of general circulation and/or the Official Gazette.
